![]() |
|
||||||||||||||||||||||||||||||
Our Company
The Company's business model capitalizes on inventions and technology from which profits are created through licensing. MSI is dedicated to earning profit for its 8,600 shareholders by identifying, supporting, patenting and marketing technical innovation by harvesting top technology talent to bring game-changing product to the market. We emphasize novel technology in the Nanomedicine space with the potential to be disruptive and the ability to establish sustainable businesses. We are "patient capital" with experienced business building partners who bring the perspective of merchant bankers, not venture capitalists. Our approach to assist scientists to commercialize their work is by providing a forum within which the commercialization process is fostered through partnerships with existing companies (Fortune/1000 or larger). The entrepreneurial scientists and engineers who join us create personal success and wealth on an accelerated basis by virtue of ownership of publicly traded Manhattan Scientifics shares (OTC BB: MHTX).
|
Our NewsDecember 19, 2011 Fortune: Manhattan Scientifics is a Leader in the Race for a Better MammogramNEW YORK--(BUSINESS WIRE)--"The race is on for a better mammogram" states the December 19th headline in Fortune Magazine's (online) story by Sierra Jiminez. December 15, 2011 Manhattan Scientifics CEO Issues Letter to ShareholdersThis letter is my opportunity to summarize what has transpired in 2011 and to share with you some of our plans for the coming year. October 31, 2011 "Breast Cancer Research" Publishes Key Study; Cancer-Sensing Technology is Radiation-Free and 100 X More Sensitive Than MammogramsALBUQUERQUE, N.M.--(BUSINESS WIRE)--Manhattan Scientifics (OTCBB: MHTX) announced today that "Breast Cancer Research," an international, peer-reviewed online journal, has published results of a study using Senior Scientific's nanomagnetic technology. October 13, 2011 Watching Cancer Cells Disappear During TherapyALBUQUERQUE, N.M.--(BUSINESS WIRE)--Manhattan Scientifics (OTCBB: MHTX) announced today that the National Cancer Institute (NCI) has funded a grant for its Senior Scientific, LLC unit, for the use of its proprietary, highly precise magnetic cancer cell measurement in leukemia research for determining the progress of cancer treatment. October 04, 2011 Dr. Edward Flynn Recognized in American Physics Society Journal for His Work in Cancer DetectionALBUQUERQUE, N.M.--Dr. Edward R. Flynn Ph.D., founder of Senior Scientific, LLC, a company owned by Manhattan Scientifics (OTCBB:MHTX), has been prominently mentioned in the October issue of The America Physics Society Journal for his work in cancer detection. October, 2011 Physicists Take the Plunge as EntrepreneursA cabal of cacophonic college kids inspired Shahriar Afshar to become an entrepreneur. It was 2004, and the physicist was serving as a visiting professor at a college, temporarily residing in the dorms. "It was summer, and the kids loved playing video games and listen[ing] to loud music, which shook the whole building." October 01, 2011 Breast Cancer: How Far Have We Come?An easy at-home test? Drugs that slash your risk? These aren't science fiction -- they're real advances that are revolutionizing the way we find, treat and defeat this disease. Every October, we don pink ribbons, buy pink-hued products and support charity runs with pink logos. Has it made a difference? You bet. August 02, 2011 Manhattan Scientifics Names V. Gerald Grafe To Commercialize Senior ScientificALBUQUERQUE, N.M.--(BUSINESS WIRE)--Manhattan Scientifics (OTCBB: MHTX) today announced it has named V. Gerald Grafe to lead the commercialization of Senior Scientific. On June 6th Manhattan Scientifics announced its acquisition of Senior Scientific LLC to commercialize the groundbreaking tools for cancer detection, diagnosis, and treatment originated by Dr. Edward R. Flynn Ph.D. August 1, 2011 Nano-Structured MetalsMetals have provided the strength, durability, and other characteristics that bone implants require since the inception of orthopedics. The ability of metals to exist in the human body without significant side effects or risk of rejection are via cobalt-chromium super alloys, stainless steels, and titanium alloys — the most commonly used materials in today's orthopedic devices. June 06, 2011 Manhattan Scientifics Acquires Senior Scientific to Speed Applications of Early Cancer Detection and Treatment TechnologyALBUQUERQUE, N.M.--(BUSINESS WIRE)--In a move to accelerate applications of a novel cancer detection and treatment technology, Manhattan Scientifics (OTCBB: MHTX) today announced that it has acquired all of Senior Scientific, LLC and its affiliate Scientific Nanomedicine Inc. |
Technology
|
|||||||||||||||||||||||||||||
Manhattan Scientifics Inc. © 2008 - 2012 | Code of Ethics | Disclaimer |
|||||||||||||||||||||||||||||||